Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Axogen (AXGN) EBIT (2016 - 2026)

Axogen has reported EBIT over the past 17 years, most recently at -$2.8 million for Q1 2026.

  • For Q1 2026, EBIT fell 70.5% year-over-year to -$2.8 million; the TTM value through Mar 2026 reached -$9.0 million, down 2224.74%, while the annual FY2025 figure was -$7.8 million, 138.79% down from the prior year.
  • EBIT for Q1 2026 was -$2.8 million at Axogen, up from -$9.8 million in the prior quarter.
  • Over five years, EBIT peaked at $2.0 million in Q4 2024 and troughed at -$11.3 million in Q1 2022.
  • A 5-year average of -$3.8 million and a median of -$4.0 million in 2023 define the central range for EBIT.
  • On a YoY basis, EBIT climbed as much as 705.06% in 2025 and fell as far as 584.48% in 2025.
  • Year by year, EBIT stood at -$5.6 million in 2022, then soared by 43.05% to -$3.2 million in 2023, then skyrocketed by 163.15% to $2.0 million in 2024, then crashed by 584.48% to -$9.8 million in 2025, then surged by 71.02% to -$2.8 million in 2026.
  • Business Quant data shows EBIT for AXGN at -$2.8 million in Q1 2026, -$9.8 million in Q4 2025, and $1.9 million in Q3 2025.